CryoSurge · Hardware & S3Pulse
Lyochrysalis research platform · S3Pulse control system
CryoSurge on the Lyochrysalis and S3PulseInstruments, detection and the authority that acts
CryoSurge is read on a real machine: probes in the product, a control system that records every holder, and an authority that answers for every command.
01The Lyochrysalis research platform
The Lyochrysalis is Panacea Bio Chem’s lyophilisation research machine, built on a Virtis freeze-dryer: immersed product-temperature probes, one in each product holder; refrigeration with a high stage, a low stage and an interchange; a heat-transfer fluid (HTF) circuit with its pump and heater; vacuum instrumentation with an Inficon CDG025D capacitance gauge and a Barocel 600; and relays that S3Pulse reads back after every command.



02The loop that listens
03Detection, holder by holder
S3Pulse follows each holder’s probe on its own. When a probe that has been cooling through the supercooled zone rebounds sharply, S3Pulse records that holder’s CryoSurge: its onset, its natural peak and its return. The record is kept per formulation, so a later run of the same formulation knows where to expect its CryoSurge — and DCSN can fire its nucleation burst ahead of it.
04Authority: every command accounted for
In S3Pulse no controller switches a relay directly. Every heater, pump, valve and refrigeration command passes the Actuator Authority, which checks which controller owns that device in the current phase, executes the command and confirms it by reading the relay back; a supervisor independent of the controllers watches the process whether a controller is running, stopped or restarting.
05Heat without overshoot
During DCSA the heater is pulsed while the HTF pump runs continuously, so heat reaches the holders through a circulating fluid rather than in surges. S3Pulse’s record proves the command and the relay readback: the pump on through the warming, the hold and the final freeze, the heater pulsing on its own.
06Status, in the words S3Pulse uses
| Element | Implemented | Tested | Validated |
|---|---|---|---|
| CryoSurge detection, per holder | yes | yes | yes — recorded since early 2025, named in February 2026 |
| DCSN, nucleation on demand | yes | yes | yes — bursts recorded on the machine |
| CryoSurge-guided DCSA | yes | yes | yes, end to end in S3Pulse |
| Actuator Authority with relay readback | yes | yes | yes |
Concept: Bogdan Dicoias · Published by Panacea Bio Chem Scientific Communications · first edition, 4 November 2026 · Evidence last searched 4 November 2026 (PubMed) — every study cited here was read from its PubMed record; first-party facts come from Panacea Bio Chem’s S3Pulse records.
Panacea Peptides · Panacea Bio Chem · Bogdan Dicoias · Panacea Technologies — CryoSurge detection, DCSN and DCSA are technologies invented by Bogdan Dicoias at Panacea Bio Chem.